STAT+: Pharmalittle: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

Novo Nordisk appointed Poul Weihrauch, CEO of the Mars candy company, as board observer as it tries to boost its consumer focus